RSV F-PROTEIN-EPITOPE

European patent · EP2950886 · In force

Register entry

Publication number
EP2950886
Application number
EP14746750
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 31, 2014
Published
Dec 9, 2015
Granted
Dec 18, 2019
Protection ends at the latest
Jan 30, 2034
Next annual fee due
Jan 31, 2027
IPC classes
A61P 31/14 (2006.01)
Priority
US 201361759664 P 01.02.2013
US 201361783380 P 14.03.2013
PCT application
PCT/US2014/014054 31.01.2014
PCT publication
WO2014/121021 07.08.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Dec 18, 2019

    Granted

    Published in Swissreg on 18.12.2019

Parties

Holder

MedImmune, LLC

One MedImmune Way, Gaithersburg, MD 20878, US

Inventor

ULBRANDT, Nancy

Gaithersburg, MD 20878, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.